Dr. Mark D. Obrien, DO is a pediatrician in Fort Wayne, IN specializing in general pediatrics. He graduated from A.T. Still University, Kirksville College of Osteopathic Medicine. Dr. Mark D. Obrien, DO is affiliated with Parkview Health and PPG - Pediatrics.
Dr. Mark D. Obrien, DO graduated from A.T. Still University, Kirksville College of Osteopathic Medicine. He completed residency at Tod Children's Hospital. He is certified by the Board Certification: Pediatrics and has a state license in Indiana.
Medical School: A.T. Still University, Kirksville College of Osteopathic Medicine
Residency: Tod Children's Hospital
Board Certification: Board Certification: Pediatrics
Licensed In: Indiana
Dr. Mark D. Obrien, DO is associated with these hospitals and organizations:
Dr. Mark D. Obrien, DO has an exceptional overall rating with an average of 5.0 out of 5 stars based on 43 ratings. We collect ratings and reviews of Dr. Mark D. Obrien, DO from all over the web to help you find the right in Fort Wayne, IN.
These charts describe general payments received by Dr. Mark D. Obrien, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AstraZeneca Pharmaceuticals LP |
$82
MOVANTIK $82 |
|||||
|---|---|---|---|---|---|---|
| Shire North American Group Inc |
$57
VYVANSE $57 |
|||||
| Pfizer Inc. |
$40
LYRICA $27 |
TOVIAZ $13 |
||||
| GlaxoSmithKline, LLC. |
$28
FLULAVAL $17 |
PEDIARIX $11 |
||||
| MedImmune, LLC |
$24
Nexium $24 |
|||||
| Other |
$86
Dyanavel XR $20 |
Aptensio XR $17 |
EpiPen $13 |
TROKENDI XR $12 |
QUADRACEL $12 |
Other $12 |
| Food and Beverage | $316 |
|---|
Dr. Mark Obrien is a specialist in general pediatrics. He is affiliated with Parkview Health. After attending A.T. Still University, Kirksville College of Osteopathic Medicine for medical school, Dr. Obrien completed his residency training at Tod Children's Hospital. Patient ratings for Dr. Obrien average 5.0 stars (out of 5). Parkview Health reports that Dr. Obrien is not accepting new patients.